SCHEMBL30833282

SCHEMBL30833282

CN1C(=O)CC(=O)c2nc(Cl)ncc21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRIM24 O15164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
OPRK1 P41145 1/20 0.32
PDE4D Q08499 1/20 0.32
PIN1 Q13526 1/20 0.31
JUN P05412 1/20 0.31
NFKB1 P19838 1/20 0.31
NFKB2 Q00653 1/20 0.31
RELA Q04206 1/20 0.31
CYP11B1 P15538 1/20 0.31
CYP11B2 P19099 1/20 0.31
TYRO3 Q06418 1/20 0.30
DYRK1B Q9Y463 1/20 0.30
BMPR1B O00238 1/20 0.30
BMPR1A P36894 1/20 0.30
TGFBR1 P36897 1/20 0.30
ACVRL1 P37023 1/20 0.30
ACVR1 Q04771 1/20 0.30
CDC25A P30304 1/20 0.30
CDC25B P30305 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21663004 0.80 SMN1; SMN2 (0.34) TRIM24SMN1; SMN2OPRK1PDE4DPIN1
SCHEMBL31125012 0.72 CYP11B2 (0.38) SMN1; SMN2PIN1CYP11B1CYP11B2TYRO3
SCHEMBL30833288 0.72 TRIM24 (0.36) TRIM24BMPR1BBMPR1ATGFBR1ACVRL1
SCHEMBL29769797 0.72 CD38 (0.35)
SCHEMBL6844626 0.71 STK4 (0.49) SMN1; SMN2PIN1CYP11B1CYP11B2TYRO3
SCHEMBL30833279 0.71 OPRK1 (0.35) TRIM24OPRK1PDE4DCYP11B1CYP11B2
SCHEMBL18168138 0.70 SMN1; SMN2 (0.44) TRIM24SMN1; SMN2TYRO3DYRK1BBMPR1B
SCHEMBL21831489 0.69 TRIM24 (0.40) TRIM24OPRK1PDE4DBMPR1BBMPR1A
SCHEMBL29769801 0.69 TRIM24 (0.40) TRIM24OPRK1PDE4DBMPR1BBMPR1A
SCHEMBL29764153 0.69 TRIM24 (0.40) TRIM24OPRK1PDE4DBMPR1BBMPR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117580829-A Quinoline and azaquinolines as inhibitors of CD38 勃林格英格翰国际有限公司 2024-02-20 CN disclosed